美国 · SEC FORM 4
CORCEPT THERAPEUTICS INC
CORT · Nasdaq · CIK 0001088856 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
163 同一窗口内观察到的 Form 4 交易行
89 sales · 74 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-03-17 · BAKER G LEONARD JR.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 8,540,393
- 上期报告
- 9,350,914
- 日均成交量
- 2,389,305
- 回补天数
- 3.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 100,000 | USD 33.14 | USD 3,313,562 | SEC 申报 ↗ |
| 2021-06-11 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 150,000 | USD 21.53 | USD 3,229,500 | SEC 申报 ↗ |
| 2020-12-01 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 68 | USD 22.64 | USD 1,540 | SEC 申报 ↗ |
| 2020-11-30 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 1,109 | USD 22.80 | USD 25,285 | SEC 申报 ↗ |
| 2020-11-25 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 361 | USD 22.81 | USD 8,234 | SEC 申报 ↗ |
| 2020-11-24 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 1,429 | USD 22.93 | USD 32,767 | SEC 申报 ↗ |
| 2020-11-23 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 1,551 | USD 22.93 | USD 35,564 | SEC 申报 ↗ |
| 2020-11-18 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 2,372 | USD 17.91 | USD 42,483 | SEC 申报 ↗ |
| 2020-11-17 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 7,883 | USD 17.82 | USD 140,475 | SEC 申报 ↗ |
| 2020-11-13 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 200 | USD 17.94 | USD 3,588 | SEC 申报 ↗ |
| 2020-11-10 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 15,000 | USD 17.71 | USD 265,650 | SEC 申报 ↗ |
| 2020-11-09 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 3,786 | USD 17.96 | USD 67,997 | SEC 申报 ↗ |
| 2020-11-06 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 13,500 | USD 17.98 | USD 242,730 | SEC 申报 ↗ |
| 2020-09-01 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 25,807 | USD 12.50 | USD 322,588 | SEC 申报 ↗ |
| 2020-08-28 | BAKER G LEONARD JR | 买入 (P) | Common Stock | 20,444 | USD 12.48 | USD 255,141 | SEC 申报 ↗ |
Form 4 申报证据
261 transaction lines in the latest 365-day window; 931 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | WILSON JAMES N | 卖出 (S) | Common Stock | 10,000 | USD 114.81 | USD 1,148,083 | SEC 申报 ↗ |
| 2026-10-02 | Vieira Roberto Wandenkolk | 卖出 (S) | Common Stock | 8,333 | USD 116.10 | USD 967,448 | SEC 申报 ↗ |
| 2026-10-02 | Vieira Roberto Wandenkolk | 期权行权／转换 (M) | Common Stock | 8,333 | USD 21.63 | USD 180,243 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | WILSON JAMES N | 卖出 (S) | Common Stock | 10,000 | USD 114.81 | USD 1,148,083 | SEC 申报 ↗ |
| 2026-10-02 | Vieira Roberto Wandenkolk | 卖出 (S) | Common Stock | 8,333 | USD 116.10 | USD 967,448 | SEC 申报 ↗ |
| 2026-10-02 | Vieira Roberto Wandenkolk | 期权行权／转换 (M) | Common Stock | 8,333 | USD 21.63 | USD 180,243 | SEC 申报 ↗ |
| 2026-10-02 | Maduck Sean | 卖出 (S) | Common Stock | 24,587 | USD 116.28 | USD 2,858,884 | SEC 申报 ↗ |
| 2026-10-02 | Maduck Sean | 期权行权／转换 (M) | Common Stock | 24,587 | USD 8.27 | USD 203,334 | SEC 申报 ↗ |
| 2026-10-02 | Lyon Joseph Douglas | 卖出 (S) | Common Stock | 9,190 | USD 116.13 | USD 1,067,258 | SEC 申报 ↗ |
| 2026-10-02 | Lyon Joseph Douglas | 期权行权／转换 (M) | Common Stock | 9,190 | USD 17.18 | USD 157,864 | SEC 申报 ↗ |
| 2026-10-01 | Maduck Sean | 卖出 (S) | Common Stock | 413 | USD 115.54 | USD 47,717 | SEC 申报 ↗ |
| 2026-10-01 | Maduck Sean | 期权行权／转换 (M) | Common Stock | 413 | USD 8.27 | USD 3,416 | SEC 申报 ↗ |
| 2026-10-01 | Lyon Joseph Douglas | 卖出 (S) | Common Stock | 810 | USD 115.40 | USD 93,473 | SEC 申报 ↗ |
| 2026-10-01 | Lyon Joseph Douglas | 期权行权／转换 (M) | Common Stock | 810 | USD 13.56 | USD 10,984 | SEC 申报 ↗ |
| 2026-09-24 | Robb Gary Charles | 赠与 (G) | Common Stock | 22,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-17 | Robb Gary Charles | 期权行权／转换 (M) | Common Stock | 17,493 | USD 8.27 | USD 144,667 | SEC 申报 ↗ |
| 2026-09-16 | Vieira Roberto Wandenkolk | 卖出 (S) | Common Stock | 296 | USD 100.82 | USD 29,843 | SEC 申报 ↗ |
| 2026-09-15 | WILSON JAMES N | 卖出 (S) | Common Stock | 10,000 | USD 110.69 | USD 1,106,932 | SEC 申报 ↗ |
| 2026-09-14 | Lyon Joseph Douglas | 卖出 (S) | Common Stock | 10,000 | USD 113.50 | USD 1,134,950 | SEC 申报 ↗ |
| 2026-09-14 | Lyon Joseph Douglas | 期权行权／转换 (M) | Common Stock | 10,000 | USD 12.99 | USD 129,863 | SEC 申报 ↗ |
| 2026-09-02 | Vieira Roberto Wandenkolk | 卖出 (S) | Common Stock | 58,333 | USD 110.76 | USD 6,460,755 | SEC 申报 ↗ |
| 2026-09-02 | Vieira Roberto Wandenkolk | 期权行权／转换 (M) | Common Stock | 58,333 | USD 21.63 | USD 1,261,743 | SEC 申报 ↗ |
| 2026-09-02 | Vieira Roberto Wandenkolk | 代扣税 (F) | Common Stock | 102 | USD 113.38 | USD 11,565 | SEC 申报 ↗ |
| 2026-09-02 | Robb Gary Charles | 代扣税 (F) | Common Stock | 91 | USD 113.38 | USD 10,318 | SEC 申报 ↗ |
| 2026-09-02 | Mokari Atabak | 代扣税 (F) | Common Stock | 102 | USD 113.38 | USD 11,565 | SEC 申报 ↗ |
| 2026-09-02 | Maduck Sean | 代扣税 (F) | Common Stock | 117 | USD 113.38 | USD 13,265 | SEC 申报 ↗ |
| 2026-09-02 | Lyon Joseph Douglas | 代扣税 (F) | Common Stock | 72 | USD 113.38 | USD 8,163 | SEC 申报 ↗ |
| 2026-09-01 | Vieira Roberto Wandenkolk | 奖励／授予 (A) | Common Stock | 276 | USD 56.69 | USD 15,646 | SEC 申报 ↗ |
| 2026-09-01 | Robb Gary Charles | 奖励／授予 (A) | Common Stock | 328 | USD 56.69 | USD 18,594 | SEC 申报 ↗ |
| 2026-09-01 | Mokari Atabak | 奖励／授予 (A) | Common Stock | 276 | USD 56.69 | USD 15,646 | SEC 申报 ↗ |
| 2026-09-01 | Maduck Sean | 卖出 (S) | Common Stock | 25,000 | USD 114.43 | USD 2,860,771 | SEC 申报 ↗ |
| 2026-09-01 | Maduck Sean | 期权行权／转换 (M) | Common Stock | 25,000 | USD 8.27 | USD 206,750 | SEC 申报 ↗ |
| 2026-09-01 | Maduck Sean | 奖励／授予 (A) | Common Stock | 300 | USD 56.69 | USD 17,007 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CORT |
| CIK | 0001088856 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 931 transaction lines from 2020-01-01 to 2026-10-15 17 P purchase lines · 326 S sale lines · 588 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.